(19)
(11) EP 4 126 031 A1

(12)

(43) Date of publication:
08.02.2023 Bulletin 2023/06

(21) Application number: 21774470.5

(22) Date of filing: 23.03.2021
(51) International Patent Classification (IPC): 
A61K 39/12(1974.07)
A61K 45/06(1974.07)
A61P 31/14(2000.01)
 A61K 39/215(1980.01)
A61P 31/12(2000.01)
A61K 39/00(1974.07)
(52) Cooperative Patent Classification (CPC):
A61P 31/12; A61K 39/12; A61K 45/06; A61P 31/14; A61K 2039/523; C12N 2770/20034
(86) International application number:
PCT/IB2021/052402
(87) International publication number:
WO 2021/191796 (30.09.2021 Gazette 2021/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 24.03.2020 US 202062994057 P

(71) Applicant: EnGeneIC Molecular Delivery Pty Ltd.
Sydney NSW 2066 (AU)

(72) Inventors:
  • BRAHMBHATT, Himanshu
    Sydney, New South Wales 2066 (AU)
  • MACDIARMID, Jennifer
    Sydney, New South Wales 2066 (AU)

(74) Representative: Altmann Stößel Dick Patentanwälte PartG mbB 
Theodor-Heuss-Anlage 2
68165 Mannheim
68165 Mannheim (DE)

   


(54) COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING VIRAL INFECTIONS, INCLUDING CORONAVIRUS INFECTIONS, AND METHODS OF USING THE SAME